Star Combo Pharma Ltd. · ASX:S66

Star Combo Pharma — Share Café 'Hidden Gems' Webinar (November 2020)

21 slides from Star Combo Pharma's conference presentation, Nov 6, 2020

  1. Slide 1: Star Combo Pharma Investor Webinar Presentation (ASX announcement)

    STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 sales@starcombo.com.au 6 November 2020 ASX Announcement For personal use only Star Combo Pharma Investor Webinar Presentation Star Combo Pharma Limited (ASX: S66) (“Star Combo Pharma” or “the Company

  2. Slide 2: Share Café Webinar Investor Presentation

    For personal use only ASX: S66 SHARE CAFÉ WEBINAR INVESTOR PRESENTATION 6 November 2020

  3. Slide 3: Disclaimer

    DISCLAIMER For personal use only The information in this presentation is not a prospectus or other form of disclosure document prepared in accordance with the requirements of the Corporations Act 2001 (Cth) (Corporations Act) and will not be lodged with the Australian Securities and Investments Comm

  4. Slide 4: Company & Financial Snapshot

    For personal use only COMPANY & FINANCIAL SNAPSHOT 3

  5. Slide 5: Star Combo Pharma Snapshot

    STAR COMBO PHARMA SNAPSHOT For personal use only Star Combo Pharma (ASX:S66) is a Sydney- REVENUE EBITA (exc. significant based contract manufacturer of vitamins one-off costs) $38.8M $1.8M and beauty products with a portfolio of owned brand products and distribution capabilities +81% on FY19 $0.3M

  6. Slide 6: Corporate Overview

    CORPORATE OVERVIEW For personal use only Star Combo Pharma (ASX:S66) is a contract manufacturer of vitamins and beauty products with a portfolio of owned brand products and 1 Year Share Price Chart distribution capabilities • TGA licensed manufacturing facility in Sydney • Contract manufacturer for

  7. Slide 7: FY20 Results & Highlights

    FY20 RESULTS & HIGHLIGHTS For personal use only Revenue FY15 – FY20 FY20 activities A$ ‘000 • $33.32M private placement via Goldenmax • Shenzhen-listed company; Market cap of CNY 6 billion • Pharma division in China – access to sales/marketing expertise and distribution network 34% p.a CAGR • Minima

  8. Slide 8: Current Operations

    For personal use only CURRENT OPERATIONS 7

  9. Slide 9: Integrated Business Model

    INTEGRATED BUSINESS MODEL For personal use only There are currently six companies in the Star Combo Pharma Limited group Star Combo Pharma Ltd ASX:S66 Costar Pharma Star Combo Australia Austoyou.com Koala Mall Chinese subsidiary Laboratory Owned product brands: Services include contract • Costar Aus

  10. Slide 10: Current Manufacturing Facility

    CURRENT MANUFACTURING FACILITY For personal use only Current manufacturing facility at Smithfield, Sydney Key facility facts: • A 15,000m² purpose-built facility - established in 2004 with the capacity to expand production significantly • Commercialisation of 26 new formulations in 2020, with more i

  11. Slide 11: Owned Brands & Product Portfolio

    OWNED BRANDS & PRODUCT PORTFOLIO For personal use only Star Combo owns four branded vitamin and health supplement brands: Living Healthy, Costar, Amax and J&K. All manufactured at Living Costar Amax J&K Smithfield facility. Healthy Overview of products Health Health Supplements for Skincare and supp

  12. Slide 12: B2C Touchpoints: E-commerce & Retail Stores

    B2C TOUCHPOINTS: E-COMMERCE & RETAIL STORES For personal use only Austoyou.com e-commerce platform (acquired Feb 2019) • E-commerce platform provides direct access to Chinese consumers, with over 5,000 product lines (includes non-S66 products) • Star Combo products available on AustoYou.com since Ma

  13. Slide 13: Growth Strategy – Pillars

    GROWTH STRATEGY – 6 PILLARS For personal use only Strengthen focus on R&D • Commercialise new products for clients, via contract manufacturing and OEM service • Establish in-house testing laboratory function Invest in production capacity • 13 new production lines to be set up to improve production t

  14. Slide 14: OEM Expansion Strategy

    For personal use only OEM EXPANSION STRATEGY 13

  15. Slide 15: Growth Strategy: Contract Manufacturing

    GROWTH STRATEGY: CONTRACT MANUFACTURING For personal use only Aim: To become Australia’s market leader in the health supplement manufacturing sector Contract manufacturing competency with focus on OEM • Operational since 2004, long history of revenue-generation • OEM revenue as percentage of group r

  16. Slide 16: Capital Investment from Goldenmax

    CAPITAL INVESTMENT FROM GOLDENMAX For personal use only Significant investment expedites Star Combo Pharma’s growth strategy to become Australia’s market leader in the health supplement manufacturing sector Investment plan A$M Expand manufacturing facility at current location ~11 New site developmen

  17. Slide 17: Expansion of Manufacturing Capabilities

    EXPANSION OF MANUFACTURING CAPABILITIES For personal use only ~$11M transformational investment into Smithfield manufacturing facility Pathway to return to • Substantial investment to enhance production to facilitate profitability contract manufacturing plans • $5M to upgrade existing facility • $6M

  18. Slide 18: Expansion of Manufacturing Capabilities - Details

    EXPANSION OF MANUFACTURING CAPABILITIES - DETAILS For personal use only Expansion of production capacity set to increase volume and range of products for OEM clients • 13 new production lines set to increase manufacturing capabilities • Expected 100+% increase in production capacity • Approx. 200% g

  19. Slide 19: Expansion of Manufacturing Capabilities - Timeline

    EXPANSION OF MANUFACTURING CAPABILITIES - TIMELINE For personal use only Expected timeline Key features of completed upgraded site Activity Date Progress • TGA-licensed Commencement of acquiring 13 Sep 2020 ✓ • GMP compliant new production lines • NSW Food Authority compliant Commencement of upgradi

  20. Slide 20: Why Invest in Star Combo Pharma?

    WHY INVEST IN STAR COMBO PHARMA? For personal use only Established revenue- • 16 years of operations generating business • Revenue-generating business with vertical business model; control over supply chain • Expedited growth strategy from capital investment from strategic investor Clear growth stra

  21. Slide 21: Thank You

    For personal use only Investor relations investors@starcombo.com.au THANK YOU 20

Star Combo Pharma — Share Café 'Hidden Gems' Webinar (November 2020) on 6ix